Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Working Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 7.038.6217.227.287.74

What is the latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Working Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 7.03 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20267.03
Mar20258.62
Mar202417.22
Mar20237.28
Mar20227.74

How is Working Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Working Capital/Sales % Change
Mar2026 7.03
-18.45
Mar2025 8.62
-49.94
Mar2024 17.22
136.54
Mar2023 7.28
-5.94
Mar2022 7.74 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Working Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹65,611.5 Cr -0.6% 5.8% 11% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -1.2% -2.2% 15.8% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 1% 16.3% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 3.2% -0.8% 38.6% Stock Analytics
CIPLA ₹116,141.0 Cr -0.9% 1.6% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -1.7% -0.1% -6.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.6%

5.8%

11%

SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses